Company / SG&A per Share
Upstream Bio, Inc. SG&A per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.49
FY2025
5-year range
$0.49 / $3.62
FY2023-FY2025
Trend
-86.2%
vs FY2024
Sector context
#165 of 210
Health Care
What the data says
Upstream Bio, Inc.'s sg&a per share of $0.49 is lower than 79% of companies in the Health Care sector (FY2025). Improved from $3.62 to $0.49 over the past 2 years.
Based on SEC 10-K filings.
0.49 in FY2025.
Improved from $3.62 to $0.49 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 210This company $0.49 Sector average $40.75
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 86.2% year-over-year.
- Ranks #165 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.49 | -86.2% |
| FY2024 | $3.57 | -1.3% |
| FY2023 | $3.62 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026